EP1551334A4 - Dispositif medical permettant l'apport intraluminal d'agents pharmaceutiques - Google Patents

Dispositif medical permettant l'apport intraluminal d'agents pharmaceutiques

Info

Publication number
EP1551334A4
EP1551334A4 EP03757429A EP03757429A EP1551334A4 EP 1551334 A4 EP1551334 A4 EP 1551334A4 EP 03757429 A EP03757429 A EP 03757429A EP 03757429 A EP03757429 A EP 03757429A EP 1551334 A4 EP1551334 A4 EP 1551334A4
Authority
EP
European Patent Office
Prior art keywords
lumenal
intra
delivery
medical device
pharmaceutical agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03757429A
Other languages
German (de)
English (en)
Other versions
EP1551334A2 (fr
Inventor
Leo Rubin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1551334A2 publication Critical patent/EP1551334A2/fr
Publication of EP1551334A4 publication Critical patent/EP1551334A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2271—Neuropeptide Y
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP03757429A 2002-06-10 2003-06-10 Dispositif medical permettant l'apport intraluminal d'agents pharmaceutiques Withdrawn EP1551334A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US166059 1988-03-23
US16605902A 2002-06-10 2002-06-10
PCT/US2003/018059 WO2003103743A2 (fr) 2002-06-10 2003-06-10 Dispositif medical permettant l'apport intraluminal d'agents pharmaceutiques

Publications (2)

Publication Number Publication Date
EP1551334A2 EP1551334A2 (fr) 2005-07-13
EP1551334A4 true EP1551334A4 (fr) 2006-12-13

Family

ID=29732103

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03757429A Withdrawn EP1551334A4 (fr) 2002-06-10 2003-06-10 Dispositif medical permettant l'apport intraluminal d'agents pharmaceutiques

Country Status (5)

Country Link
EP (1) EP1551334A4 (fr)
JP (1) JP2005528956A (fr)
AU (1) AU2003243439A1 (fr)
CA (1) CA2489282A1 (fr)
WO (1) WO2003103743A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7399480B2 (en) 1997-09-26 2008-07-15 Abbott Laboratories Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances using medical devices
US10307147B2 (en) 1999-08-09 2019-06-04 Edwards Lifesciences Corporation System for improving cardiac function by sealing a partitioning membrane within a ventricle
US8257428B2 (en) 1999-08-09 2012-09-04 Cardiokinetix, Inc. System for improving cardiac function
US9694121B2 (en) 1999-08-09 2017-07-04 Cardiokinetix, Inc. Systems and methods for improving cardiac function
US8500795B2 (en) 1999-08-09 2013-08-06 Cardiokinetix, Inc. Retrievable devices for improving cardiac function
US8529430B2 (en) 2002-08-01 2013-09-10 Cardiokinetix, Inc. Therapeutic methods and devices following myocardial infarction
US7674222B2 (en) 1999-08-09 2010-03-09 Cardiokinetix, Inc. Cardiac device and methods of use thereof
US8377114B2 (en) 1999-08-09 2013-02-19 Cardiokinetix, Inc. Sealing and filling ventricular partitioning devices to improve cardiac function
US10064696B2 (en) 2000-08-09 2018-09-04 Edwards Lifesciences Corporation Devices and methods for delivering an endocardial device
US9078660B2 (en) 2000-08-09 2015-07-14 Cardiokinetix, Inc. Devices and methods for delivering an endocardial device
US9332993B2 (en) 2004-08-05 2016-05-10 Cardiokinetix, Inc. Devices and methods for delivering an endocardial device
US9332992B2 (en) 2004-08-05 2016-05-10 Cardiokinetix, Inc. Method for making a laminar ventricular partitioning device
WO2007130724A2 (fr) 2006-02-06 2007-11-15 Northwind Ventures Systèmes et procédés de réduction de volume
US8404281B2 (en) 2009-06-08 2013-03-26 Avant Garde Therapeutics & Technologies Llc Formulations
EP2493417B1 (fr) 2009-10-26 2017-06-21 Cardiokinetix, Inc. Réduction du volume ventriculaire
US20140328933A1 (en) * 2010-06-16 2014-11-06 Shaker Mousa Novel formulations and methods
JP2015503954A (ja) * 2011-12-15 2015-02-05 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォードジュニア ユニバーシティＴｈｅ Ｂｏａｒｄ ｏｆ Ｔｒｕｓｔｅｅｓ ｏｆ ｔｈｅ Ｌｅｌａｎｄ Ｓｔａｎｆｏｒｄ Ｊｕｎｉｏｒ Ｕｎｉｖｅｒｓｉｔｙ 肺高血圧症を治療するための装置および方法
BR112017006248A2 (pt) 2014-09-28 2017-12-12 Cardiokinetix Inc aparelhos para o tratamento de insuficiência cardíaca
US10898330B2 (en) 2017-03-28 2021-01-26 Edwards Lifesciences Corporation Positioning, deploying, and retrieving implantable devices

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039103A1 (fr) * 1995-06-06 1996-12-12 Quanam Medical Corporation Extenseur intravasculaire
WO2001085218A2 (fr) * 2000-05-11 2001-11-15 Eastman Chemical Company Cyclodextrine acylee: complexes d"inclusion de molecule incluse
WO2003030943A1 (fr) * 2001-10-09 2003-04-17 The University Of British Columbia Compositions comprenant hydroxyapatite utilisees pour administrer des agents therapeutiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613753B2 (en) * 2001-02-21 2003-09-02 Supergen, Inc. Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039103A1 (fr) * 1995-06-06 1996-12-12 Quanam Medical Corporation Extenseur intravasculaire
WO2001085218A2 (fr) * 2000-05-11 2001-11-15 Eastman Chemical Company Cyclodextrine acylee: complexes d"inclusion de molecule incluse
WO2003030943A1 (fr) * 2001-10-09 2003-04-17 The University Of British Columbia Compositions comprenant hydroxyapatite utilisees pour administrer des agents therapeutiques

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FRASE L L ET AL: "Cardiovascular effects of vasoactive intestinal peptide in healthy subjects.", THE AMERICAN JOURNAL OF CARDIOLOGY. 1 DEC 1987, vol. 60, no. 16, 1 December 1987 (1987-12-01), pages 1356 - 1361, XP002404699, ISSN: 0002-9149 *

Also Published As

Publication number Publication date
AU2003243439A8 (en) 2003-12-22
CA2489282A1 (fr) 2003-12-18
EP1551334A2 (fr) 2005-07-13
AU2003243439A1 (en) 2003-12-22
WO2003103743A2 (fr) 2003-12-18
JP2005528956A (ja) 2005-09-29
WO2003103743A3 (fr) 2004-07-22

Similar Documents

Publication Publication Date Title
AU2003297621A8 (en) Medical devices for delivery of therapeutic agents
AU2003295614A8 (en) Delivery of pharmaceutical agents via the human insulin receptor
GB0313604D0 (en) Delivery device for powdered medicament
AU2003243439A8 (en) Medical device for intra-lumenal delivery of pharmaceutical agents
EP1648327A4 (fr) Dispositifs buccaux et procedes d'administration controlee de medicament
AU2003299849A8 (en) Drug delivery apparatus
AU2003286639A8 (en) Mixing and delivery medical syringe system for therapeutic compositions
PL368207A1 (en) Ophthalmic drug delivery device
AU2003243305A8 (en) Implantable medication delivery device
AU2003251563A1 (en) Implatable or insertable medical devices for controlled delivery of a therapeutic agent
EP1684669A4 (fr) Dispositif d'adminstration pour medicament ophthalmique
IL163725A0 (en) Administration of agents for the treatment of inflammation
HUE040600T2 (hu) Állatgyógyászati gyógyszer-leadó készülék
GB2385273B (en) Drug delivery device
AU2003281810A1 (en) Medical delivery device
AUPR553701A0 (en) A device for the delivery of a drug to a fractured bone
AU2003231260A8 (en) Catechin multimers as therapeutic drug delivery agents
IL149377A0 (en) Pharmaceutical formulation comprising melatonin
AU2003250317A8 (en) Device for administration of fluids
AU2003224316A8 (en) Device for delivery of biologically active agents
AU2003230034A8 (en) Transdermal delivery device for the administration of fentanyl
GB0201607D0 (en) Formulation for the administration of medicinal substances
GB0210020D0 (en) Medical agent delivery
ZA200603126B (en) Pharmaceutical compositions for therapeutic use
AU2003254672A8 (en) Dual-spike release formulation for oral drug delivery

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050107

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20061110

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070102